Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Grape seed extract (GSE) hydrogel is an experimental intracanal medication being evaluated for regenerative endodontic procedures, specifically the revascularization of necrotic permanent immature teeth in children. Developed by researchers at Al-Azhar University, this formulation utilizes a 6.5% concentration of grape seed extract, which is rich in proanthocyanidins. These polyphenolic compounds function as potent antioxidants and natural cross-linkers of dentin collagen, which helps stabilize the collagen matrix and improve the mechanical properties of the root canal walls. Additionally, GSE exhibits antimicrobial properties that assist in disinfecting the canal space, creating a favorable environment for the ingrowth of new vital tissue (revascularization) in teeth with pulp necrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on grape seed extract hydrogel.